Pancreatic cancer/X
Nov 12, 2024, 18:58
Erman Akkus: First-line chemotherapies in advanced pancreatic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post X:
“First-line chemotherapies in advanced pancreatic cancer, The Lancet Oncology.
Meta-analysis reaffirms NALIRIFOX /FOLFIRINOX as first-line regimens.”
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 05:54
Dec 21, 2024, 05:42
Dec 21, 2024, 04:55
Dec 21, 2024, 03:42
Dec 21, 2024, 03:31